Sponsor or institution
Clinical trials and research at Cardiac Rsk3 Inhibitors, LLC
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $4.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
CRI-103 gene therapy for dilated cardiomyopathy
A new gene therapy called CRI-103 aims to help adults with dilated cardiomyopathy by blocking a key heart-regulating protein interaction to prevent harmful heart remodeling.
-
New therapy targeting RSK3 to improve heart failure outcomes
This study is testing a new treatment that uses a virus to deliver a special peptide to heart cells, which could help prevent heart failure by stopping harmful changes in the heart, and it aims to improve heart function and quality of life for people with heart issues.
-
New therapy targeting heart failure mechanisms
This study is exploring a new way to help people with heart failure by looking at how certain proteins in heart cells work together, and it hopes to improve heart function for patients who are dealing with this condition.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.